Skip to main navigation Skip to search Skip to main content

Radiolabeling of Gold Nanoparticles With Lu-177 as a Platform for Cancer Theranostics

    Research output › peer-review

    Abstract

    In cancer radiotherapy, gold nanoparticles (AuNPs) have emerged as promising radiosensitizers, which accumulate in the tumor and increase the effectiveness of external beam radiotherapy by local production of reactive oxygen species (ROS) and secondary electrons upon irradiation. Five nm gold nanoparticles surrounded by an organic shell of polyallylamine (PAA) are produced by plasma vapor deposition and are conjugated to anti-EGFR-antibodies (Cetuximab-Ctxb) for active tumor targeting (AuNPs-PAA-Ctxb). In order to increase the therapeutic effect of the AuNPs-PAA-Ctxb, we aim to radiolabel the nanoparticles with 177Lu.
    Original languageEnglish
    Title of host publicationAnnual Congress of the European Association of Nuclear Medicine October 12 – 16, 2019 Barcelona, Spain
    PagesS752
    Number of pages1
    Volume46
    EditionS1
    DOIs
    StatePublished - 31 Dec 2019

    Publication series

    NameEuropean Journal of Nuclear Medicine and Molecular Imaging
    PublisherSpringer
    ISSN (Print)1619-7070

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. Good health and well being
      Good health and well being

    Cite this